Crohns Disease: Clinical Trials

7 trials for Crohns Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 active not recruiting, 1 completed, 1 not yet recruiting. 7 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 27Unknown 2, Active not recruiting 1, Completed 1, Not yet recruiting 1, Recruiting 1, Withdrawn 1
Phase 11Recruiting 1
Phase 31Unknown 1

Follow Crohns Disease: new trials by email Literature Review of Crohns Disease trials Research Report on Crohns Disease

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oral N-acetylglucosamine in Crohn's Disease
N-Acetylglucosamine (GlcNAc) - Crohns Disease
Phase 2Not yet recruitingJohns Hopkins University402026-11-012026-09-11
Treatment of Moderate to Severe Refractory Crohn's Disease
TRX103, Cyclophosphamide - Crohns Disease
Phase 1 / Phase 2RecruitingTr1X, Inc.392025-05-052025-12-10
Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease
Afimkibart - Crohns Disease
Phase 2Active not recruitingHoffmann-La Roche212023-07-242026-09-16
Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's Disease
GSK2330811, Placebo - Crohns Disease, Crohn's Disease
Phase 2WithdrawnGlaxoSmithKline2021-04-052022-01-14
A Double Blind Placebo Control Study to Assess the Safety,Tolerability and Efficacy of Copaxone in Crohn's Disease
glatiramer acetate, placebo - Crohns Disease
Phase 2UnknownTel-Aviv Sourasky Medical Center502008-09-012009-03-03
Atorvastatin in Moderate Active Crohns Disease
Atorvastatin - Crohns Disease
Phase 2CompletedSkane University Hospital122006-10-012007-10-22
Vitamin D Treatment for Crohn´s Disease
Vitamin D - Crohns Disease
Phase 2 / Phase 3UnknownUniversity of Aarhus1102005-09-012007-04-13

Narrower conditions

Crohn Disease (7)  ·  Abdominal Pain (1)

Broader conditions

Digestive System Diseases (7)  ·  Gastroenteritis (7)  ·  Gastrointestinal Diseases (7)  ·  Inflammatory Bowel Diseases (7)  ·  Intestinal Diseases (7)  ·  Neurologic Manifestations (1)  ·  Pain (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Signs and Symptoms, Digestive (1)

Interventions

Acetylglucosamine (1)  ·  Atorvastatin (1)  ·  Cyclophosphamide (1)  ·  Glatiramer Acetate (1)  ·  Vitamin D (1)

Sponsors

GlaxoSmithKline (1)  ·  Hoffmann-La Roche (1)  ·  Johns Hopkins University (1)  ·  Skane University Hospital (1)  ·  Tel-Aviv Sourasky Medical Center (1)  ·  Tr1X, Inc. (1)  ·  University of Aarhus (1)

Countries

United States (3)  ·  Belgium (1)  ·  Denmark (1)  ·  France (1)  ·  Israel (1)  ·  Poland (1)  ·  Sweden (1)

Top investigators

Anders Bredberg, MD, PhD (1)  ·  Gunnel Bredberg, MD, PhD (1)  ·  Iris Dotan, MD (1)  ·  Jens F. Dahlerup, MD, DrMedSc (1)  ·  Joanna Melia, MD (1)  ·  Olof Grip, MD, PhD (1)

Results publications

PMID 19421322

NIH funding

2005 (1), 2023 (1), R01DK141870 (1)